Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases

Clinical trial NCT06619808 · RECRUITING

Trial details

NCT number: NCT06619808
Sponsor: Jinling Hospital, China
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Dysfunction-associated Steatotic Liver Disease Hepatic Steatosis Non-alcoholic Fatty Liver Diseases

Start date: 2024-07-29
Primary completion: 2026-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.